In the prostate cancer cell lines, DU145 and PC3, KAI1/CD82 reduced both integrin-dependent and HGF-induced activation of c-Met, subsequently inhibiting signaling to activate Src, resulting in reduced activation of p130Cas [68]. Here, CD82 is linked to Familial prostate cancer.